Financhill
Sell
35

HNRG Quote, Financials, Valuation and Earnings

Last price:
$10.92
Seasonality move :
14.14%
Day range:
$10.87 - $11.48
52-week range:
$4.33 - $14.00
Dividend yield:
0%
P/E ratio:
8.76x
P/S ratio:
0.98x
P/B ratio:
1.46x
Volume:
361.4K
Avg. volume:
572.1K
1-year change:
20.57%
Market cap:
$465.8M
Revenue:
$634.5M
EPS (TTM):
-$0.59
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $317.4M $244.2M $247.7M $362M $634.5M
Revenue Growth (YoY) 8.79% -23.06% 1.4% 46.16% 75.28%
 
Cost of Revenues $247.9M $186M $198.8M $266.6M $473.4M
Gross Profit $69.6M $58.3M $48.8M $95.4M $161.1M
Gross Profit Margin 21.92% 23.86% 19.72% 26.35% 25.39%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $12.8M $11.6M $14.8M $16.4M $26.2M
Other Inc / (Exp) -$71.9M -$813K $11.8M $1.3M -$2M
Operating Expenses $63.9M $53.4M $53.3M $65M $96.1M
Operating Income $5.7M $4.9M -$4.5M $30.4M $65M
 
Net Interest Expenses $16M $13M $11.1M $11.9M $13.7M
EBT. Incl. Unusual Items -$82.2M -$8.9M -$3.7M $19.9M $49.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$22.3M -$2.7M $26K $1.8M $4.5M
Net Income to Company -$59.9M -$6.2M -$3.8M $18.1M $44.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$59.9M -$6.2M -$3.8M $18.1M $44.8M
 
Basic EPS (Cont. Ops) -$1.95 -$0.20 -$0.12 $0.57 $1.35
Diluted EPS (Cont. Ops) -$1.95 -$0.20 -$0.12 $0.55 $1.25
Weighted Average Basic Share $30.3M $30.4M $30.6M $32M $33.1M
Weighted Average Diluted Share $30.3M $30.4M $30.6M $33.6M $36.8M
 
EBITDA -$17.6M $41.4M $44.8M $75M $126.9M
EBIT -$66.2M $1.8M $4.8M $28.1M $59.7M
 
Revenue (Reported) $317.4M $244.2M $247.7M $362M $634.5M
Operating Income (Reported) $5.7M $4.9M -$4.5M $30.4M $65M
Operating Income (Adjusted) -$66.2M $1.8M $4.8M $28.1M $59.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $65.2M $79.8M $85.1M $165.8M $105M
Revenue Growth (YoY) -21.28% 22.34% 6.59% 94.83% -36.63%
 
Cost of Revenues $46.6M $67.8M $64.6M $76.9M $49.6M
Gross Profit $18.7M $12M $20.5M $88.9M $55.4M
Gross Profit Margin 28.63% 15.07% 24.13% 53.61% 52.74%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.1M $3.1M $3.6M $43.7M $33.2M
Other Inc / (Exp) -$923K $10.8M $168K -$1.7M -$234K
Operating Expenses $13M $13.4M $15.1M $65.1M $50.7M
Operating Income $5.7M -$1.4M $5.4M $23.8M $4.7M
 
Net Interest Expenses $3.3M $2.8M $3.4M $3M $2.7M
EBT. Incl. Unusual Items $1.5M $6.6M $2.2M $19.1M $1.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$461K -$1.4M $596K $3M $232K
Net Income to Company $1.9M $8M $1.6M $16.1M $1.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.9M $8M $1.6M $16.1M $1.6M
 
Basic EPS (Cont. Ops) $0.06 $0.26 $0.05 $0.49 $0.04
Diluted EPS (Cont. Ops) $0.06 $0.26 $0.05 $0.44 $0.04
Weighted Average Basic Share $30.5M $30.6M $33M $33.1M $42.6M
Weighted Average Diluted Share $30.5M $30.6M $33.3M $36.8M $43M
 
EBITDA $13.5M $18.6M $15.8M $37.8M $17.9M
EBIT $4.2M $8.8M $4.6M $21.5M $4M
 
Revenue (Reported) $65.2M $79.8M $85.1M $165.8M $105M
Operating Income (Reported) $5.7M -$1.4M $5.4M $23.8M $4.7M
Operating Income (Adjusted) $4.2M $8.8M $4.6M $21.5M $4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $256.8M $247.8M $275.4M $667.4M $424.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $191.3M $199M $225.1M $381M $414.5M
Gross Profit $65.5M $48.8M $50.3M $286.3M $10.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $12.3M $12.1M $16M $98.7M -$33.6M
Other Inc / (Exp) -$75.9M $13.3M $692K -$1.9M -$3.8M
Operating Expenses $58.2M $53.3M $56.2M $176.5M $20.4M
Operating Income $7.3M -$4.5M -$5.9M $109.8M -$10.1M
 
Net Interest Expenses $14.9M $11.6M $10.9M $14M $13.6M
EBT. Incl. Unusual Items -$83.6M -$2.8M -$16.1M $93.9M -$27.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$22.3M -$2.1M $3.6M $8.9M -$6.9M
Net Income to Company -$61.3M -$747K -$19.7M $85.1M -$20.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$61.3M -$747K -$19.7M $85.1M -$20.6M
 
Basic EPS (Cont. Ops) -$2.00 -$0.02 -$0.64 $2.62 -$0.59
Diluted EPS (Cont. Ops) -$2.00 -$0.02 -$0.64 $2.45 -$0.59
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$26.7M $45.6M $33.6M $170.4M $43.3M
EBIT -$69.8M $6.2M -$8.4M $104M -$15.5M
 
Revenue (Reported) $256.8M $247.8M $275.4M $667.4M $424.8M
Operating Income (Reported) $7.3M -$4.5M -$5.9M $109.8M -$10.1M
Operating Income (Adjusted) -$69.8M $6.2M -$8.4M $104M -$15.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $178.6M $182.2M $209.9M $515.3M $305.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $131.2M $144.3M $170.6M $285M $181.1M
Gross Profit $47.4M $37.9M $39.4M $230.3M $124.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8.8M $9.3M $10.4M $92.8M $73.5M
Other Inc / (Exp) $980K $12.5M $1.4M -$1.8M -$3.5M
Operating Expenses $40.6M $40.6M $43.5M $155.1M $124.4M
Operating Income $6.8M -$2.7M -$4.1M $75.3M $159K
 
Net Interest Expenses $12.5M $8.5M $8.3M $10.5M $10.4M
EBT. Incl. Unusual Items -$4.7M $1.3M -$11.1M $63M -$13.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$3.3M -$2.7M $840K $8M -$3.4M
Net Income to Company -$1.5M $4M -$11.9M $55M -$10.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.5M $4M -$11.9M $55M -$10.3M
 
Basic EPS (Cont. Ops) -$0.05 $0.13 -$0.39 $1.67 -$0.28
Diluted EPS (Cont. Ops) -$0.05 $0.13 -$0.39 $1.52 -$0.28
Weighted Average Basic Share $91.3M $91.8M $94.6M $99.3M $115.3M
Weighted Average Diluted Share $91.3M $91.8M $94.9M $110.3M $115.7M
 
EBITDA $36.7M $37.8M $26.7M $122M $38.3M
EBIT $6.5M $7.9M -$5.2M $70.6M -$4.6M
 
Revenue (Reported) $178.6M $182.2M $209.9M $515.3M $305.6M
Operating Income (Reported) $6.8M -$2.7M -$4.1M $75.3M $159K
Operating Income (Adjusted) $6.5M $7.9M -$5.2M $70.6M -$4.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $8.8M $8M $2.5M $3M $2.8M
Short Term Investments $245K -- -- -- --
Accounts Receivable, Net $25.6M $14.4M $13.6M $29.9M $19.9M
Inventory $40.1M $33.6M $17.7M $78.1M $62M
Prepaid Expenses $3.2M $3.3M $2.1M $4.5M $2.3M
Other Current Assets -- -- -- -- --
Total Current Assets $82.4M $63.3M $39.2M $138.5M $91.3M
 
Property Plant And Equipment $329.7M $309.4M $302.8M $480.5M $488.6M
Long-Term Investments $3.1M $3.2M $3.5M $4M $2.8M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $4.2M $1.8M $1.7M $1.6M $1.5M
Total Assets $425.6M $384.1M $354M $630.6M $589.8M
 
Accounts Payable $16.1M $14.8M $27.8M $62.3M $43.6M
Accrued Expenses $9.4M $8.3M $7.6M $11.7M $10.5M
Current Portion Of Long-Term Debt -- $5.5M -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $3.9M
Other Current Liabilities -- $2.8M $867K -- --
Total Current Liabilities $64.8M $71.2M $64.6M $239.6M $157.6M
 
Long-Term Debt $140.6M $101.8M $84.7M $68.7M $82.5M
Capital Leases -- -- -- -- --
Total Liabilities $230.1M $194.9M $167.7M $415.5M $321.2M
 
Common Stock $304K $306K $308K $330K $341K
Other Common Equity Adj -- -- -- -- --
Common Equity $191.5M $185.3M $182.2M $215M $268.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $4M $4M $4M -- --
Total Equity $195.5M $189.3M $186.2M $215M $268.6M
 
Total Liabilities and Equity $425.6M $384.1M $354M $630.6M $589.8M
Cash and Short Terms $9M $8M $2.5M $3M $2.8M
Total Debt $173.6M $141.6M $107.8M $101.7M $106.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $5.3M $4.5M $7M $2.6M $3.8M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $15.8M $16.5M $16.7M $20.7M $11.9M
Inventory $46M $21.1M $28.7M $60.8M $70.7M
Prepaid Expenses $4.8M $3.7M $2.2M $4.2M $6M
Other Current Assets -- -- -- -- --
Total Current Assets $76.1M $49.1M $58.2M $92.3M $99.8M
 
Property Plant And Equipment $312.5M $302.2M $313.3M $482.7M $472.1M
Long-Term Investments $3.3M $3.3M $4.1M $3M $2.1M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.8M $1.7M $1.6M $7.2M $5.8M
Total Assets $400.2M $363.1M $383.4M $585.2M $579.7M
 
Accounts Payable $14.2M $20.9M $33.1M $52.5M $23.4M
Accrued Expenses $9.6M $10.7M $13.2M $11.1M $7.2M
Current Portion Of Long-Term Debt $2.2M -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $6.2M
Other Current Liabilities $3M $1.6M -- -- --
Total Current Liabilities $70M $66M $162.6M $171.6M $171.6M
 
Long-Term Debt $113.7M $83.5M $19M $55.5M $42.9M
Capital Leases -- -- -- -- --
Total Liabilities $206.5M $169M $199.4M $313.5M $260.9M
 
Common Stock $305K $306K $330K $332K $426K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $4M $4M -- -- --
Total Equity $193.7M $194.1M $184M $271.7M $318.8M
 
Total Liabilities and Equity $400.2M $363.1M $383.4M $585.2M $579.7M
Cash and Short Terms $5.3M $4.5M $7M $2.6M $3.8M
Total Debt $150.2M $110.3M $129.2M $76.7M $67M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$59.9M -$6.2M -$3.8M $18.1M $44.8M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $1.8M $1.2M $1M $1.3M $3.6M
Change in Accounts Receivable -$7.3M $11.2M $830K -$16.3M $10M
Change in Inventories -$10.7M $5.8M $15.9M -$32.1M $5M
Cash From Operations $38.2M $52.6M $48M $54.2M $59.4M
 
Capital Expenditures $35.5M $20.7M $28.1M $54M $75.4M
Cash Acquisitions -- -$113K -- -- --
Cash From Investing -$30.2M -$18.2M -$27.5M -$53.4M -$75.3M
 
Dividends Paid (Ex Special Dividend) -$5M -$1.2M -- -- --
Special Dividend Paid
Long-Term Debt Issued $33.8M $17.3M $20.3M $80.7M $77.1M
Long-Term Debt Repaid -$42.1M -$49.7M -$46.2M -$78.2M -$59.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.6M -$2M -$692K -$2.7M -$796K
Cash From Financing -$14.8M -$35.6M -$26.7M -$207K $16.6M
 
Beginning Cash (CF) $20.1M $13.3M $12.1M $5.8M $6.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$6.8M -$1.2M -$6.2M $597K $697K
Ending Cash (CF) $13.3M $12.1M $5.8M $6.4M $7.1M
 
Levered Free Cash Flow $2.7M $31.9M $19.9M $149K -$15.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.9M $8M $1.6M $16.1M $1.6M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $291K $267K $122K $773K $1.1M
Change in Accounts Receivable -$2.4M -$2.1M $411K $736K $7.2M
Change in Inventories $4.9M $20.5M -$2.7M $21M $1.3M
Cash From Operations $16.9M $24.1M $13.7M $35.3M -$12.9M
 
Capital Expenditures $4M $7.2M $15.4M $18.1M $11.6M
Cash Acquisitions -$113K -- -- -- --
Cash From Investing -$5.1M -$7.2M -$15.4M -$18.1M -$10.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $3M $23M $7M $24.5M
Long-Term Debt Repaid -$14.2M -$18.2M -$21M -$19.5M -$1.4M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1K -- -$2.1M -$4.4M -$578K
Cash From Financing -$14.2M -$15.2M -$105K -$16.8M $22.5M
 
Beginning Cash (CF) $11.9M $6.1M $12.4M $6.4M $10.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.3M $1.7M -$1.9M $346K -$1.1M
Ending Cash (CF) $9.5M $7.8M $10.5M $6.7M $9.6M
 
Levered Free Cash Flow $13M $16.9M -$1.8M $17.1M -$24.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$61.3M -$747K -$19.7M $85.1M -$20.6M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $1.3M $1.1M $400K $3.8M $4.1M
Change in Accounts Receivable $5.7M -$617K -$289K -$3.9M $8.8M
Change in Inventories -$8.5M $24.8M -$7.6M -$15M -$10M
Cash From Operations $36M $55.5M $24.9M $119.8M $6.9M
 
Capital Expenditures $22.3M $24.8M $48.3M $64.4M $66.2M
Cash Acquisitions -$113K -- -- -- --
Cash From Investing -$17.7M -$24.8M -$47M -$64.5M -$62.8M
 
Dividends Paid (Ex Special Dividend) -$2.5M -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $32.8M $14.3M $72.7M $47M $117.9M
Long-Term Debt Repaid -$47.8M -$46.2M -$44.9M -$99M -$98.9M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$477K -$3M -$7.1M $5.4M
Cash From Financing -$19.8M -$32.5M $24.8M -$59.1M $58.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.5M -$1.8M $2.7M -$3.8M $2.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $13.8M $30.7M -$23.4M $55.3M -$59.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.5M $4M -$11.9M $55M -$10.3M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $927K $834K $230K $2.8M $3.3M
Change in Accounts Receivable $9.7M -$2M -$3.2M $9.2M $8M
Change in Inventories -$6.6M $12.4M -$11M $6.2M -$8.8M
Cash From Operations $34.1M $37M $13.9M $79.5M $27M
 
Capital Expenditures $14M $18.1M $38.3M $48.7M $39.6M
Cash Acquisitions -$113K -- -- -- --
Cash From Investing -$11.5M -$18.1M -$37.6M -$48.7M -$36.2M
 
Dividends Paid (Ex Special Dividend) -$1.2M -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $17.3M $14.3M $66.7M $33M $73.8M
Long-Term Debt Repaid -$40.5M -$37.1M -$35.7M -$56.5M -$95.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.9M -$420K -$2.7M -$7.1M -$927K
Cash From Financing -$26.4M -$23.2M $28.3M -$30.6M $11.8M
 
Beginning Cash (CF) $37.8M $25.8M $25.8M $19.1M $24.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.8M -$4.3M $4.7M $290K $2.5M
Ending Cash (CF) $34.1M $21.5M $30.4M $19.4M $26.7M
 
Levered Free Cash Flow $20.1M $19M -$24.4M $30.8M -$12.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock